Mitochondrial implications in human pregnancies with intrauterine growth restriction and associated cardiac remodelling
暂无分享,去创建一个
E. Gratacós | F. Crispi | J. Grau | C. Morén | L. Youssef | G. Garrabou | F. Cardellach | M. Guitart-Mampel | J. Milisenda | L. García-Otero | M. Catalán-García | Í. González-Casacuberta | D. Juárez-Flores | E. Tobías | V. Roca-Agujetas | Ingrid González‐Casacuberta
[1] V. Desquiret-Dumas,et al. Study of mitochondrial function in placental insufficiency. , 2018, Placenta.
[2] C. Maack,et al. Metabolic remodelling in heart failure , 2018, Nature Reviews Cardiology.
[3] Josep Maria Salanova Grau,et al. Cardiac and placental mitochondrial characterization in a rabbit model of intrauterine growth restriction. , 2018, Biochimica et biophysica acta. General subjects.
[4] A. Orekhov,et al. The role of mitochondrial dysfunction in cardiovascular disease: a brief review , 2018, Annals of medicine.
[5] Caixia Liu,et al. SIRT3: A New Regulator of Cardiovascular Diseases , 2018, Oxidative medicine and cellular longevity.
[6] Eduard Gratacós,et al. Long-term cardiovascular consequences of fetal growth restriction: biology, clinical implications, and opportunities for prevention of adult disease. , 2018, American journal of obstetrics and gynecology.
[7] S. Rohrbach,et al. Heart and Mitochondria: Pathophysiology and Implications for Cardiac Surgeons , 2017, The Thoracic and Cardiovascular Surgeon.
[8] E. Gratacós,et al. Cord Blood Biomarkers of Cardiac Dysfunction and Damage in Term Growth-Restricted Fetuses Classified by Severity Criteria , 2017, Fetal Diagnosis and Therapy.
[9] G. Macones,et al. Early Second-Trimester Fetal Growth Restriction and Adverse Perinatal Outcomes. , 2017, Obstetrics and gynecology.
[10] I. Cetin,et al. Mitochondrial DNA content and methylation in fetal cord blood of pregnancies with placental insufficiency. , 2017, Placenta.
[11] M. Dekker Nitert,et al. Review: Placental mitochondrial function and structure in gestational disorders. , 2017, Placenta.
[12] Z. Tuncer,et al. Placental respiratory chain complex activities in high risk pregnancies , 2017, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[13] J. Gatell,et al. HIV‐1 promonocytic and lymphoid cell lines: an in vitro model of in vivo mitochondrial and apoptotic lesion , 2016, Journal of cellular and molecular medicine.
[14] C. Bode,et al. SIRT3 in Cardiac Physiology and Disease , 2016, Front. Cardiovasc. Med..
[15] A. Zorzano,et al. Mitochondrial DNA disturbances and deregulated expression of oxidative phosphorylation and mitochondrial fusion proteins in sporadic inclusion body myositis. , 2016, Clinical science.
[16] A. Molina,et al. Blood cell respirometry is associated with skeletal and cardiac muscle bioenergetics: Implications for a minimally invasive biomarker of mitochondrial health , 2016, Redox biology.
[17] K. Koike,et al. Cardiovascular Remodeling and Dysfunction Across a Range of Growth Restriction Severity in Small for Gestational Age Infants - Implications for Fetal Programming. , 2016, Circulation journal : official journal of the Japanese Circulation Society.
[18] F. Crispi,et al. Human fetal growth restriction: a cardiovascular journey through to adolescence. , 2016, Journal of developmental origins of health and disease.
[19] D. Sharma,et al. Intrauterine Growth Restriction: Antenatal and Postnatal Aspects , 2016, Clinical medicine insights. Pediatrics.
[20] B. Bijnens,et al. Fetal cardiovascular remodeling persists at 6 months in infants with intrauterine growth restriction , 2015, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[21] P. de Mazancourt,et al. Involvement of estrogen-related receptor-γ and mitochondrial content in intrauterine growth restriction and preeclampsia. , 2015, Fertility and sterility.
[22] N. Abril,et al. Alterations of protein expression in serum of infants with intrauterine growth restriction and different gestational ages. , 2015, Journal of proteomics.
[23] V. Tsatsaris,et al. Transcriptomic analysis of human placenta in intrauterine growth restriction , 2015, Pediatric Research.
[24] L. Li,et al. SIRT3 protects cells from hypoxia via PGC-1α- and MnSOD-dependent pathways , 2015, Neuroscience.
[25] Claire T. Roberts,et al. Placental Adaptations in Growth Restriction , 2015, Nutrients.
[26] Enrico Grisan,et al. Early origins of adult disease: low birth weight and vascular remodeling. , 2014, Atherosclerosis.
[27] H. Speisky,et al. Polyphenols and mitochondria: an update on their increasingly emerging ROS-scavenging independent actions. , 2014, Archives of biochemistry and biophysics.
[28] S. Hernández,et al. Mitochondrial Toxicity in Human Pregnancy: An Update on Clinical and Experimental Approaches in the Last 10 Years , 2014, International journal of environmental research and public health.
[29] E. Gratacós,et al. Survey on the Current Trends in Managing Intrauterine Growth Restriction , 2014, Fetal Diagnosis and Therapy.
[30] E. Clementi,et al. Placental mitochondrial content and function in intrauterine growth restriction and preeclampsia. , 2014, American journal of physiology. Endocrinology and metabolism.
[31] E. Gratacós,et al. Update on the Diagnosis and Classification of Fetal Growth Restriction and Proposal of a Stage-Based Management Protocol , 2014, Fetal Diagnosis and Therapy.
[32] Q. Tong,et al. Regulation of Skeletal Muscle Oxidative Capacity and Muscle Mass by SIRT3 , 2014, PloS one.
[33] Philip A. Kramer,et al. A review of the mitochondrial and glycolytic metabolism in human platelets and leukocytes: Implications for their use as bioenergetic biomarkers , 2014, Redox biology.
[34] J. Dopazo,et al. Intrauterine growth restriction is associated with cardiac ultrastructural and gene expression changes related to the energetic metabolism in a rabbit model. , 2013, American journal of physiology. Heart and circulatory physiology.
[35] M. Hemberger,et al. A placenta for life. , 2012, Reproductive biomedicine online.
[36] M. Sack. The role of SIRT3 in mitochondrial homeostasis and cardiac adaptation to hypertrophy and aging. , 2012, Journal of molecular and cellular cardiology.
[37] M. Sack. Emerging characterization of the role of SIRT3-mediated mitochondrial protein deacetylation in the heart. , 2011, American journal of physiology. Heart and circulatory physiology.
[38] Francesc Figueras,et al. Intrauterine growth restriction: new concepts in antenatal surveillance, diagnosis, and management. , 2011, American journal of obstetrics and gynecology.
[39] G. Donders,et al. Placental pathology in fetal growth restriction. , 2011, European journal of obstetrics, gynecology, and reproductive biology.
[40] J. Mazat,et al. Development and implementation of standardized respiratory chain spectrophotometric assays for clinical diagnosis. , 2009, Mitochondrion.
[41] I. Cetin,et al. The role of the placenta in intrauterine growth restriction (IUGR). , 2009, Zeitschrift fur Geburtshilfe und Neonatologie.
[42] I. Cetin,et al. Intrauterine growth restriction: implications for placental metabolism and transport. A review. , 2009, Placenta.
[43] I. Cetin,et al. Higher mitochondrial DNA content in human IUGR placenta. , 2008, Placenta.
[44] Shiwei Song,et al. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis , 2008, Proceedings of the National Academy of Sciences.
[45] Elisenda Eixarch,et al. Cardiac dysfunction and cell damage across clinical stages of severity in growth-restricted fetuses. , 2008, American journal of obstetrics and gynecology.
[46] Ò. Miró,et al. Neuroleptic Treatment Effect on Mitochondrial Electron Transport Chain: Peripheral Blood Mononuclear Cells Analysis in Psychotic Patients , 2007, Journal of clinical psychopharmacology.
[47] O. Vuolteenaho,et al. Cardiovascular hemodynamics and umbilical artery N‐terminal peptide of proB‐type natriuretic peptide in human fetuses with growth restriction , 2007, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[48] L. Poston,et al. Placental-related diseases of pregnancy: Involvement of oxidative stress and implications in human evolution. , 2006, Human reproduction update.
[49] L. Myatt. Placental adaptive responses and fetal programming , 2006, The Journal of physiology.
[50] Ò. Miró,et al. Enzymatic diagnosis of oxidative phosphorylation defects on muscle biopsy: better on tissue homogenate or on a mitochondria-enriched suspension? , 2004, Medical science monitor : international medical journal of experimental and clinical research.
[51] A. Wu,et al. The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma. , 2004, Clinica chimica acta; international journal of clinical chemistry.
[52] B. Brenner,et al. Haemostatic mechanisms in human placenta. , 2003, Best practice & research. Clinical haematology.
[53] A. Barrientos. In vivo and in organello assessment of OXPHOS activities. , 2002, Methods.
[54] H. C. Lee,et al. Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. , 2000, The Biochemical journal.
[55] I. Hassinen,et al. Placental Mitochondrial DNA and Respiratory Chain Enzymes in the Etiology of Preeclampsia , 1998, Obstetrics and gynecology.
[56] T. Schimmel,et al. Birth of infant after transfer of anucleate donor oocyte cytoplasm into recipient eggs , 1997, The Lancet.
[57] Marta Nuñez-Garcia,et al. Persistence of Cardiac Remodeling in Preadolescents With Fetal Growth Restriction , 2017, Circulation. Cardiovascular imaging.
[58] E. Gratacós,et al. An integrated approach to fetal growth restriction. , 2017, Best practice & research. Clinical obstetrics & gynaecology.
[59] Pablo Laguna,et al. Heart morphology differences induced by intrauterine growth restriction and preterm birth measured on the ECG at preadolescent age. , 2016, Journal of electrocardiology.
[60] Pablo Laguna,et al. Heart morphology differences induced by intrauterine growth restriction and premature birth measured on the ECG in pre-adolescents , 2015, 2015 Computing in Cardiology Conference (CinC).
[61] J. Kingdom,et al. Screening, diagnosis, and management of intrauterine growth restriction. , 2012, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.
[62] N. Illsley,et al. Placental metabolic reprogramming: do changes in the mix of energy-generating substrates modulate fetal growth? , 2010, The International journal of developmental biology.
[63] A. S. Prilutskii,et al. [A method of separating mononuclears on a density gradient]. , 1990, Laboratornoe delo.